Overview

Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients With Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Phase:
Phase 2
Details
Lead Sponsor:
Anhui Provincial Hospital
Treatments:
Apatinib